Laryngeal Diseases clinical trials

The registry lists 147 studies for Laryngeal Diseases across more than 10 countries. 26 are recruiting or about to start. 53 of them are mainly about Laryngeal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 10 narrower conditions too, such as Laryngeal Neoplasms: 790 studies, 184 open.

Get an email when these change. Save the Laryngeal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 77
Terminated: 21
Recruiting: 21
Status unknown: 10
Withdrawn: 6
Active, not recruiting: 5

Phase

Phase 2: 30
Phase 3: 16
Phase 1: 14
Phase 4: 7
Early Phase 1: 5

Where

United States: 72
France: 18
Belgium: 13
Italy: 12
Germany: 9
Spain: 8

Who runs them

University of Chicago (5) · Vanderbilt University (4) · Vanderbilt-Ingram Cancer Center (3) · National Cancer Institute (NCI) (3) · Sidney Kimmel Cancer Center at Thomas Jefferson University (3) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · Boston Medical Center (2) · Memorial Sloan Kettering Cancer Center (2)

What is being tested here

Drugs under test in Laryngeal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Ficerafusp alfa	2	1	2
Panitumumab	2	0	2
IRDye800	2	0	2
Cisplatin	1	2	7
Cetuximab	1	0	5
Zopapogene imadenovec	1	0	1
Triamcinolone Acetonide	1	0	1
Triamcinolone	1	0	1
Fluorouracil	1	0	1
Docetaxel	1	0	1

Drug classes tested here Antimetabolites 1 open · Tyrosine kinase inhibitors (TKIs) 1 open · Immune checkpoint inhibitors 6 · Proton pump inhibitors (PPIs) 3

Coming up

4phase 3 studies under way

6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Dec 2026AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study · Ruijin Hospital
Jan 2027Force Sensor Study · University of California, San Francisco
Feb 2027Effect of Passive Music Therapy Via an App on Anxiety Prevention in ENT Surgery · Clinique Saint-Vincent
Mar 2027Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma · Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
May 2027High-Resolution PET-CT Imaging for Surgical Margin Visualization · Vanderbilt-Ingram Cancer Center
Jun 2027Efficacy of Intramuscular Steroid Injection for Chronic Cough. · Medical University of South Carolina

Who these studies take

Of the 21 Laryngeal Diseases studies recruiting now, 17 (81%) set no upper age limit and 1 (5%) stop at 75 or younger. 3 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (10%) take healthy volunteers.

Recruiting studies that take each age, of 21
Age	Women	Men
10	2 (10%)	2 (10%)
18	20 (95%)	20 (95%)
30	21 (100%)	21 (100%)
40	21 (100%)	21 (100%)
50	21 (100%)	21 (100%)
65	21 (100%)	21 (100%)
75	20 (95%)	20 (95%)
85	19 (90%)	19 (90%)

Across all 147 studies, recruiting or not: 19% stop at 75 or younger and 12% at 65; 18% take children; 2% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Laryngeal Diseases studies take

Of 29 interventional studies with no phase under Laryngeal Diseases, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	24 mo13–52 · 29 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 147. Browse all 147 → or search them.